Evidence map›Paper›PMID 35899213›Full record

ArticleFrontiers in medicine2022

Immunoinformatic Approach to Contrive a Next Generation Multi-Epitope Vaccine Against

Kashaf Khalid, Umar Saeed, Mohammad Aljuaid, Mohammad Ishtiaq Ali, Awais Anjum, Yasir Waheed

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Design of a Novel Peptide-Based Vaccine TargetingInternational journal of dentistry · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Therapeutic advances in respiratory disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Kashaf KhalidMultidisciplinary Laboratory, Foundation University Islamabad, Islamabad, Pakistan.
Umar SaeedBiological Production Division, National Institute of Health, Islamabad, Pakistan.
Mohammad AljuaidDepartment of Health Administration, College of Business Administration, King Saud University, Riyadh, Saudi Arabia.
Mohammad Ishtiaq AliDepartment of Microbiology, Quaid-i-Azam University, Islamabad, Pakistan.
Awais AnjumPerkinElmer Inc., Newport, United Kingdom.
Yasir WaheedClinical and Biomedical Research Center, Foundation University Islamabad, Islamabad, Pakistan.
Foundation University Islamabad · PKKing Saud University · SANational Institute of Health · PKPerkinElmer (United Kingdom) · GBQuaid-i-Azam University · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Achromobacter xylosoxidans, previously identified as

Indexed as

Achromobacter xylosoxidansdockinggram-negative bacteriaImmunoinformatic approachesmulti-epitope vaccine

Identifiers

PMID35899213
PMCPMC9309517
OpenAlexW4285008605

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.